Detection bias is a known challenge in prostate cancer research, as increased medical surveillance or diagnostic investigations, such as PSA testing, following a history of kidney stones, could lead to the incidental detection of asymptomatic, low-grade tumors. This evidence concerns the gene KLK3 and prostate cancer.